This Consortium of 10 geographically-dispersed clinical research sites will continue to study rare diseases of the airways that are associated wit defective mucociliary clearance and airway host defense mechanisms, which result in chronic airways infection and/or bronchiectasis. These disorders include Primary Ciliary Dyskinesia (PCD), idiopathic bronchiectasis (IB), cystic fibrosis (CF), airway infection with non-tuberculous mycobacteria (NTM), rare immune disorders (e.g., RAG1 deficiency), and Cri du Chat syndrome (chr 5pminus;deletion) complicated by concomitant PCD, caused by mutations in DNAH5 (chr5p). Over the past 5 years of this Consortium's work, we have made remarkable progress that is already impacting on clinical practice, particularly in PCD and associated disorders. One major advance was the development of a non-invasive test for PCD (measurement of nasal nitric oxide, NO). This test is now validated as a useful clinical test for PCD, and we are participating in the European BESTCILIA grant to help them implement our methodology for nNO testing in Europe. Our Consortium played a critical role in identifying PCD-causing mutations in 28 genes, which we think will be responsible for the genetic cause of PCD in >70%) of PCD patients. We have developed a genetic test panel containing those 28 genes (Ampliseq), which is being technically validated. On the clinical side, we discovered that PCD-causing mutations are associated with heterotaxy and congenital heart disease (CHD). This discovery resulted in follow-up studies, which showed worse post-operative clinical outcomes for CHD-heterotaxy patients, and has led to a call for genetic studies of patients with CHD. Along different lines, we developed a rigorous quality-of-life (QOL) instrument for PCD, which will be a key outcome measure for therapeutic clinical trials in PCD. Finally, we have developed novel preliminary data that patients with idiopathic bronchiectasis share phenotypic features with heritable connective tissue disorders, including dural ectasia, which may reflect underlying genetic variants. Taken together, the proposed work will lead to earlier diagnoses, improved care, and more effective therapeutic interventions for rare airway diseases.

Public Health Relevance

This RDCRN Consortium research has high public health relevance to our understanding of genetic diseases of the lung. This proposal will define the clinical course and develop new genetic test panels for PCD, and define subgroups of patients with idiopathic bronchiectasis that may have underlying genetic variants that cause heritable disorders of connective tissue. The proposed work will lead to earlier diagnoses and more effective therapy for airways disease.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
2U54HL096458-11
Application #
8764245
Study Section
Special Emphasis Panel (ZTR1-CI-8 (01))
Program Officer
Smith, Robert A
Project Start
2004-08-06
Project End
2019-07-31
Budget Start
2014-09-19
Budget End
2015-07-31
Support Year
11
Fiscal Year
2014
Total Cost
$1,249,998
Indirect Cost
$358,505
Name
University of North Carolina Chapel Hill
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
608195277
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Bustamante-Marin, Ximena M; Ostrowski, Lawrence E (2016) Cilia and Mucociliary Clearance. Cold Spring Harb Perspect Biol :
Knowles, Michael R; Zariwala, Maimoona; Leigh, Margaret (2016) Primary Ciliary Dyskinesia. Clin Chest Med 37:449-61
Horani, Amjad; Ferkol, Thomas W (2016) Primary ciliary dyskinesia and associated sensory ciliopathies. Expert Rev Respir Med 10:569-76
Shapiro, Adam J; Zariwala, Maimoona A; Ferkol, Thomas et al. (2016) Diagnosis, monitoring, and treatment of primary ciliary dyskinesia: PCD foundation consensus recommendations based on state of the art review. Pediatr Pulmonol 51:115-32
Polineni, Deepika; Davis, Stephanie D; Dell, Sharon D (2016) Treatment recommendations in Primary Ciliary Dyskinesia. Paediatr Respir Rev 18:39-45
Milla, Carlos E (2016) The evolving spectrum of ciliopathies and respiratory disease. Curr Opin Pediatr 28:339-47
Merkel, Peter A; Manion, Michele; Gopal-Srivastava, Rashmi et al. (2016) The partnership of patient advocacy groups and clinical investigators in the rare diseases clinical research network. Orphanet J Rare Dis 11:66
Dell, Sharon D; Leigh, Margaret W; Lucas, Jane S et al. (2016) Primary Ciliary Dyskinesia: First Health-related Quality-of-Life Measures for Pediatric Patients. Ann Am Thorac Soc 13:1726-1735
Horani, Amjad; Ferkol, Thomas W; Dutcher, Susan K et al. (2016) Genetics and biology of primary ciliary dyskinesia. Paediatr Respir Rev 18:18-24
Leigh, Margaret W; Ferkol, Thomas W; Davis, Stephanie D et al. (2016) Clinical Features and Associated Likelihood of Primary Ciliary Dyskinesia in Children and Adolescents. Ann Am Thorac Soc 13:1305-13

Showing the most recent 10 out of 51 publications